Validating biomarkers of treatable mechanisms in irritable bowel syndrome - Wikidata - awgldk - TriplyDB

Validating biomarkers of treatable mechanisms in irritable bowel syndrome

Validating biomarkers of treatable mechanisms in irritable bowel syndrome

http://www.wikidata.org/entity/Q34577283

about

The quest for biomarkers in IBS-where should it lead us?Biomarkers of Irritable Bowel Syndrome Systematic review with meta-analysis: the prevalence of bile acid malabsorption in the irritable bowel syndrome with diarrhoea Bile Acid diarrhea: prevalence, pathogenesis, and therapy Faecal short-chain fatty acids - a diagnostic biomarker for irritable bowel syndrome?Review article: biomarkers and personalised therapy in functional lower gastrointestinal disorders.Early investigational therapeutics for gastrointestinal motility disorders: from animal studies to Phase II trials.Systematic review with meta-analysis: the accuracy of diagnosing irritable bowel syndrome with symptoms, biomarkers and/or psychological markers.Recent advances in the diagnosis of irritable bowel syndrome.Drug discovery approaches to irritable bowel syndrome.Biomarkers for bile acid diarrhoea in functional bowel disorder with diarrhoea: a systematic review and meta-analysis.Serum biomarkers for irritable bowel syndrome.Performance characteristics of serum C4 and FGF19 measurements to exclude the diagnosis of bile acid diarrhoea in IBS-diarrhoea and functional diarrhoea.Bile Acid Deficiency in a Subgroup of Patients With Irritable Bowel Syndrome With Constipation Based on Biomarkers in Serum and Fecal Samples.Biomarkers as a diagnostic tool for irritable bowel syndrome: where are we?Enhancing Diagnostic Performance of Symptom-Based Criteria for Irritable Bowel Syndrome by Additional History and Limited Diagnostic Evaluation.Pharmacotherapy for Irritable Bowel Syndrome.Irritable Bowel Syndrome: Pathophysiology and Current Therapeutic Approaches.Irritable Bowel Syndrome.

P2860

Q27024239-93BFA8F0-8240-489D-9DA4-5BB841CDDFB7 Q28069902-6EF88A5E-4C8A-4D9E-938F-1CCDAD36A671 Q28081213-DA68D625-BED0-4ED6-BD73-3AE501A6583C Q28086845-F66D53BF-6D05-46BD-A2CD-6CB0308E593B Q36001130-F3409047-5B77-4BE3-91A3-A1003E7D33AD Q36021269-3D06FF51-94FF-42FF-A100-75CD6F8C3EFB Q36082843-8B1D16F0-14E0-4C44-B1AC-07C964822A1C Q38528017-24A74FB4-31E4-49D2-A0E0-EFFBF7B9E7D9 Q38545062-C9B791CC-0F76-49C6-A627-EA69050C2663 Q38550878-DFD44A3E-1846-494B-ACE5-334FB4065293 Q38582664-AD87621F-2A4C-499C-B18B-6AF1388C3F4D Q38648339-463ED8D3-6464-4CFD-9311-01C36AFE03B0 Q38687017-7D9F76B2-2C8D-4DF6-8683-491EBBA0DDD4 Q38699388-AC1BC304-BA27-49D4-AB0A-3D5456925801 Q38765085-CDF580FD-DAF2-445A-9D65-67E3D70B03B0 Q39535724-B1974160-25BA-411E-A81B-15DBD1CDC26A Q47117277-54E753AF-6786-4FFB-8004-DF08142F466B Q48389586-985054CE-9657-44AE-8490-7E96056788FE Q50861627-23EEC3E3-4464-4D40-A855-B348025AC686

P2860

Validating biomarkers of treatable mechanisms in irritable bowel syndrome

http://www.wikidata.org/entity/Q34577283

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Validating biomarkers of treatable mechanisms in irritable bowel syndrome

@ast

Validating biomarkers of treatable mechanisms in irritable bowel syndrome

@en

Validating biomarkers of treatable mechanisms in irritable bowel syndrome

@nl

type

label

Validating biomarkers of treatable mechanisms in irritable bowel syndrome

@ast

Validating biomarkers of treatable mechanisms in irritable bowel syndrome

@en

Validating biomarkers of treatable mechanisms in irritable bowel syndrome

@nl

prefLabel

Validating biomarkers of treatable mechanisms in irritable bowel syndrome

@ast

Validating biomarkers of treatable mechanisms in irritable bowel syndrome

@en

Validating biomarkers of treatable mechanisms in irritable bowel syndrome

@nl

P1433

Q34577283-7E50769E-4730-4E1F-968B-227812A3FB27

P1476

Q34577283-6E1923F4-987D-4F90-B5B7-8551DFD63A24

P2093

Q34577283-128806F4-8CCA-4EF5-94F8-2ED7B146515F

Q34577283-30B4787F-CB31-42EB-AF91-AF0BCF41DCD1

Q34577283-30F1ADF6-0F17-4C01-9DB8-AFEC15C5A0B2

Q34577283-44427DD2-7079-4C86-B6AB-1ED9FDFFD461

Q34577283-5328A6FA-4217-4CE4-8E67-429C32C4AEE8

Q34577283-5CF54CB1-008A-4BE4-BA41-0FC2B4C7E880

Q34577283-6983A246-FA74-4A46-B25B-4B1A522343AE

Q34577283-7FBEC8C6-F9E8-4700-A519-98073C6263E1

Q34577283-E5C7AAE1-C258-4045-88EC-ED2F320AE9C1

Q34577283-FD952DE4-5325-4C08-8216-68F194E95DCE

P2860

Q34577283-051FC760-DC23-435C-AACC-3B7133F6D376

Q34577283-098C505C-0E39-4E98-B113-635D782324E6

Q34577283-2739CD31-A439-404A-A928-A36491B55708

Q34577283-2A0D839C-7B7F-47CB-AAC1-CC5EE879B2FF

Q34577283-314DE73C-E217-466F-A439-DD7F4FF12F13

Q34577283-36F2D566-8914-4E59-93A7-E85F81D27495

Q34577283-3DD03D80-3B17-4D8F-8538-2BBDAF150B85

Q34577283-3F0D034B-4412-4DB6-862C-B54AB8E298E9

Q34577283-49457AEC-BE5F-40B2-9002-13F61D405775

Q34577283-4D094D23-75B5-42CD-840F-A222EDF07E29

P304

Q34577283-10CD58E3-A375-497B-8D36-DCCE2E64E3FD

P31

Q34577283-C3C717A7-06DC-4916-8DBB-EB7B449D35EA

P356

Q34577283-D1342D60-F274-4C37-9746-79472EE26B99

P433

Q34577283-52CC3301-3D6A-4B40-8984-828882FCCFDE

P478

Q34577283-DCEEB9E1-19EA-4BDF-8C83-B86912F7C608

P50

Q34577283-A3A1A07F-26DF-4BEF-A44D-64D5B3121F8C

P577

Q34577283-96A4E5C0-5E2B-4A6F-8073-C378624B6572

P5875

Q34577283-EC17F2E1-E1A1-4A16-8A72-E815BE1AFE3B

P698

Q34577283-81ADFC02-15F5-4BB9-B64A-070F90A36BD4

P921

Q34577283-C36827F3-0C75-4C61-9619-2F66B0D2991D

P932

Q34577283-DA4EFF6F-4F37-4A06-A9C6-94F1D22C7430

P356

P1433

Neurogastroenterology and Motility

P1476

Validating biomarkers of treatable mechanisms in irritable bowel syndrome

@en

P2093

A Acosta

http://www.w3.org/2001/XMLSchema#string

A E Bharucha

http://www.w3.org/2001/XMLSchema#string

A Lueke

http://www.w3.org/2001/XMLSchema#string

A Shin

http://www.w3.org/2001/XMLSchema#string

D Burton

http://www.w3.org/2001/XMLSchema#string

I Busciglio

http://www.w3.org/2001/XMLSchema#string

J Lamsam

http://www.w3.org/2001/XMLSchema#string

L J Donato

http://www.w3.org/2001/XMLSchema#string

M Camilleri

http://www.w3.org/2001/XMLSchema#string

P Carlson

http://www.w3.org/2001/XMLSchema#string

P2860

Chenodeoxycholate in females with irritable bowel syndrome-constipation: a pharmacodynamic and pharmacogenetic analysis

Effects of chenodeoxycholate and a bile acid sequestrant, colesevelam, on intestinal transit and bowel function

Towards positive diagnosis of the irritable bowel

The hospital anxiety and depression scale

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

Validation of the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care

Functional bowel disorders

Colonic transit time and IBS symptoms: what's the link?

A combined nutrient and lactulose challenge test allows symptom-based clustering of patients with irritable bowel syndrome.

Understanding measurements of intestinal permeability in healthy humans with urine lactulose and mannitol excretion.

P304

1677-1685

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/NMO.12421

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P50

Alan R. Zinsmeister

P577

2014-09-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

265912115

http://www.w3.org/2001/XMLSchema#string

P698

25244349

http://www.w3.org/2001/XMLSchema#string

P921

P932

4245393

http://www.w3.org/2001/XMLSchema#string